In ovo feeding of epidermal growth factor: embryonic expression of intestinal epidermal growth factor receptor and posthatch growth performance and intestinal development in broiler chickens

Effects of Formula Product Injection on Hatching Parameters, Small Intestinal Development and Ileum Histology in Breeder Chicken Eggs

BACKGROUND AND OBJECTIVE

This study aimed to determine the effects of in ovo formula product injection on hatching parameters, chick quality, small intestinal development and ileum histology of breeder hen eggs.

METHODS

A total of 400 fertilised eggs were obtained from the Atak-S parent flock at 42 weeks of age for the experiment. The experiment was designed in two groups: a control group (C), in which no injection was performed, and the other group in which a solution containing formula products at concentrations of 1.25% (F1), 2.5% (F2) and 5% (F3) was injected into 0.5 mL/egg air sac. The hatching rate, embryonic mortality and discard chick rate were examined at the end of the trial.

RESULTS

The best result of the hatching rate was found in the Group F2, while there was no difference between the control and Group F1 regarding these parameters. The weight and length of the quality chicks were promoted in the Group F1. In Group F3, the injection of the formula product at a rate of 5% had a negative effect on parameters such as hatchability, embryonic mortality, chick length, Pasgar score and yolk sac weight compared to the other groups. Otherwise, in Group F2, there was a significant increase in villus height, crypt depth and lamina muscularis mucosa thickness compared to the other groups (p < 0.01).

CONCLUSIONS

As a result, it has been concluded that the appropriate rates for the formula product application on chicks are 1.25% and 2.5%, considering the positive effects of the 1.25% and 2.5% rates and the negative effects of the 5% rate.

The in ovo screening of 27 single essential oils showed selective effects on hatchability, performance and gene expression relevant to gut functions in broilers at hatch

The early post-hatching phase remains to be one of the most vulnerable phases in broiler production. Some essential oils have been reported to improve gut health and growth in broiler chickens when applied to post-hatching diets. However, in-feed applications are unable to prevent the health challenges observed immediately after hatching. Thus, pre-hatch interventions need to be considered. A research project was developed with the aim of investigating the impact of in ovo application of 27 selected essential oils (EOs) on foetal development with emphasis on gut integrity in broiler hatchlings. The eggs were incubated under standard conditions until day 17.5, when 1 mL of each EO preparation (5 µL EO + 5 µL polysorbate-80 + 990 µL saline) was injected into the amnion. Hatchability, body weight and organ weights (residual yolk, gizzard-proventriculus, intestines, liver, and heart) were measured at hatch. Five essential oils eugenol, clove, tea tree, lemongrass, and thyme, significantly (P < 0.05) reduced hatchability (66.67 %, 58.33, 83.30 and 83.30 %) compared to the saline (96.80 %), were discarded from the rest of the study. The other 22 essential oils were investigated in a second phase to assess their impact on expression of gut biomarkers including: a) jejunum integrity; b) digestive enzymes and nutrient transporters; and c) immune system. The results indicated that lemon myrtle significantly increased and oregano EO decreased body weight at hatch (BW0) compared to the saline (P < 0.05). Ylang ylang, clary sage, bergamot, lemon myrtle, and black pepper upregulated the expressions of biomarkers regulating gut integrity and barrier functions (ZO-1, ZO-2, CLDN1, MARVELD2, EGFR and EGF), nutrients transporters (EAAT3, PEPT1, I-FABP1, SGLT1), and digestive enzymes (APN, SI). Ylang ylang, turmeric acid, star anise, clary sage, and black pepper upregulated the expression of gut immunity biomarkers IL1B, IL10, IGMH, CD3D, and BU1 compared to the saline. In conclusion, in ovo delivery of selected EOs has the potential to improve embryonic development relevant to nutrient digestion and absorption, gut integrity and immunity in broilers.

Impact of early postbiotic supplementation on broilers' responses to subclinical necrotic enteritis

Necrotic enteritis (NE), an enteric disease caused by Clostridium perfringens, results in damage to the intestinal epithelial lining disrupting its function, nutrient absorption, and utilization. This study evaluated the effects of in ovo and post-hatch applications of a Saccharomyces cerevisiae-based postbiotic on performance and nutrient transporter genes of broilers during a NE challenge. At embryonic d 18, Ross 708 fertile eggs were injected with 0.2 mL of either water or postbiotic. A total of 288 male hatchlings were assigned to one of the following treatment groups: 1) NC (in ovo water injection, no challenge); 2) PIW (postbiotic in ovo and in drinking water, no challenge); 3) NC+ (NC with NE challenge); and 4) PIW+ (PIW with NE challenge). On d 14, all birds in the NE-challenged groups were orally gavaged with 3,000 Eimeria maxima sporulated oocysts followed by two doses of ∼1×108 CFU/mL/bird of C. perfringens on d 19 and d 20. Hatchability, weekly performance, intestinal lesion scores, and mRNA abundance of nutrient transporters in the jejunum and ileum were assessed. Data were analyzed by 2-way ANOVA in JMP and significance between treatments identified by LSD test (P ≤ 0.05). A significant postbiotic treatment and NE challenge interaction was observed in performance during d 21-28 with a greater ADG in PIW compared to NC and PIW+. Lesion scores in the jejunum and ileum were significantly reduced in PIW+ compared to NC+. On d 7, mRNA abundance of SGLT1 was significantly greater in PIW compared to the NC group. On d 14, birds in PIW had greater levels of GLUT2 and EAAT3 than NC group. No significant interaction effects were observed on d 21. PIW+ had significantly greater EAAT3 mRNA levels compared to PIW in jejunum and PIW and NC+ in ileum on d 28. In conclusion, in ovo and water supplementation of this postbiotic presents a potential to improve the performance, ameliorate pathology detriments associated with NE, and positively regulate the mRNA levels of key nutrient transporters during NE challenge.

Dietary inclusion of defatted silkworm (Bombyx mori L.) pupa meal in broiler chickens: phase feeding effects on nutritional and sensory meat quality

The present experiment was conducted to test the effect of a 4% defatted silkworm (Bombyx mori) pupae meal (SWM) incorporation into chickens' diets at different growth phases on meat quality characteristics and sensory traits. Ninety ROSS 308 day-old male broiler chickens were randomly assigned to 3 dietary groups, with 5 replicated pens/diet: the first group received a control (C) diet throughout the growing period of 42 d, the second group received a diet with 4% SWM (SWM1) during the starter phase (1-10 d) and the C diet up to slaughter, whereas the third group was fed the C diet during the starter phase and 4% SWM during the grower and finisher phases (SWM2). Diets were isonitrogenous and isoenergy, and birds had free access to feed and water throughout the experimental trial. At 42 d of age, 15 chickens/treatment were slaughtered at a commercial abattoir. Fatty acid (FA) and amino acid (AA) profiles and contents of meat, as well as its oxidative status, were determined in both breast and leg meat cuts. Also, a descriptive sensory analysis was performed on breast meat by trained panelists. Results highlighted that the SWM2 treatment increased the n-3 proportion and content in both breast and leg meat, thereby improving the omega-6/omega-3 (n-6/n-3) ratio in both cuts (P < 0.001). However, the dietary treatment had no significant effect on the oxidative status of either breast or leg meat (P > 0.05). The SWM had a limited impact on overall sensory traits of breast meat, but it contributed to improve meat tenderness in SWM-fed chickens (P < 0.01). Furthermore, SWM1 meat exhibited higher juiciness (P < 0.05) and off flavor intensity (P < 0.05) compared to the control meat. Overall, the present experiment indicated that defatted SWM holds promise as an alternative ingredient in chicken rations, ensuring satisfactory meat quality. Furthermore, administering SWM during the grower-finisher phase demonstrated beneficial effects on meat healthiness, ultimately enhancing n-3 fatty acids content and reducing the n-6/n-3 ratio.

Physiological effects of in ovo delivery of bioactive substances in broiler chickens

The poultry industry has improved genetics, nutrition, and management practices, resulting in fast-growing chickens; however, disturbances during embryonic development may affect the entire production cycle and cause irreversible losses to broiler chicken producers. The most crucial time in the chicks' development appears to be the perinatal period, which encompasses the last few days of pre-hatch and the first few days of post-hatch. During this critical period, intestinal development occurs rapidly, and the chicks undergo a metabolic and physiological shift from the utilization of egg nutrients to exogenous feed. However, the nutrient reserve of the egg yolk may not be enough to sustain the late stage of embryonic development and provide energy for the hatching process. In addition, modern hatchery practices cause a delay in access to feed immediately post-hatch, and this can potentially affect the intestinal microbiome, health, development, and growth of the chickens. Development of the in ovo technology allowing for the delivery of bioactive substances into chicken embryos during their development represents a way to accommodate the perinatal period, late embryo development, and post-hatch growth. Many bioactive substances have been delivered through the in ovo technology, including carbohydrates, amino acids, hormones, prebiotics, probiotics and synbiotics, antibodies, immunostimulants, minerals, and microorganisms with a variety of physiological effects. In this review, we focused on the physiological effects of the in ovo delivery of these substances, including their effects on embryo development, gastrointestinal tract function and health, nutrient digestion, immune system development and function, bone development, overall growth performance, muscle development and meat quality, gastrointestinal tract microbiota development, heat stress response, pathogens exclusion, and birds metabolism, as well as transcriptome and proteome. We believe that this method is widely underestimated and underused by the poultry industry.

Luteolin Attenuates APEC-Induced Oxidative Stress and Inflammation via Inhibiting the HMGB1/TLR4/NF-κB Signal Axis in the Ileum of Chicks

Avian pathogenic E. coli (APEC) is typically the cause of avian colibacillosis, which can result in oxidative stress, inflammation, and intestinal damage (APEC). Luteolin, in the form of glycosylation flavone, has potent anti-inflammatory and anti-oxidative properties. However, its effects on APEC-induced intestinal oxidative stress and NF-κB-mediated inflammation in chicks remains poorly understood. After hatching, one-day-old chicks were stochastically assigned to four groups: a control group (basic diet), an E. coli group (basic diet) and L10 and L20 groups (with a dry matter of luteolin diet 10 mg/kg and 20 mg/kg, respectively), with fifteen chicks in each group and one repeat per group. They were pretreated for thirteen days. The body weight, mortality, histopathological changes in the ileum, antioxidant status, and the mRNA and protein-expression levels of factors associated with the HMGB1/TLR4/NF-κB signal axis of the chicks were measured. The results showed that luteolin treatment decreased the mRNA and protein-expression level of the related factors of HMGB1/TLR4/NF-κB signal axis in the ileum, reduced inflammation, increased antioxidant enzyme activity, and reduced intestinal injury. Collectively, luteolin alleviated APEC-induced intestinal damage by means of hindering the HMGB1/TLR4/NF-κB signal axis, which suggests that luteolin could be a good method for the prevention and treatment of avian colibacillosis.

Effects of early feeding of enzymatically treated yeast on growth performance, organ weights, intestinal histomorphology and ceca microbial metabolites in broiler chickens subjected to Eimeria challenge

The study evaluated effects of early feeding of enzymatically treated yeast on growth performance and selected physiological responses in broiler chickens. A total of 480-day-old (male) Ross × Ross 708 broiler chicks were placed in 24 floor pens (20 birds per pen) and allocated to 2 diets (control vs. yeast) in a completely randomized block design (n = 12). Diets were formulated for a 5-phase feeding program: Pre-starter; d 0 to 6 Starter; d 7 to 15, Grower: d 16 to 28, Finisher 1; d 28 to 42 and Finisher 2; d 43 to 56. The yeast was applied in pre-starter and starter diets at 0.6 and 0.2%, respectively. Birds received a common diet from d 16 to 56. Feed intake (FI) and body weight (BW) were recorded by phase for calculation of BW gain (BWG) and FCR. On d 10, all birds received an oral dose of 25,000 E. acervullina and 5,000 E. maxima sporulated oocysts in 1 mL of sterile saline. On d 15 post-hatch, one bird per pen was sacrificed for organ weights (gizzard, small intestine, ceca, liver, spleen, liver, and bursa), jejunal tissues for histomorphology and ceca digesta for microbial activity. On d 56, one bird per pen was sacrificed for organs and breast weight. In pre-starter phase, yeast fed birds showed improved (P < 0.05) BWG and FCR than control fed birds. Combining pre-starter and starter phases, the FCR of yeast fed birds showed improved FCR (1.115 vs. 1.135; P < 0.05) than control. The overall BWG (d 0–56) was 3.920 and 3.962 kg/ bird and corresponding values for FCR were, 1.808 and 1.755, for the control and yeast, respectively. Diets had no (P > 0.05) effects on physiological responses evaluated on necropsied birds except that yeast birds had (P < 0.05) lighter bursa than control birds on d 15. The current data indicated that yeast could support growth in early life of broiler chickens, but these effects were not sustained after the transitioning birds to common grower and finisher diets.

Efficacy of dietary supplementary probiotics as substitutes for antibiotic growth promoters during the starter period on growth performances, carcass traits, and immune organs of male layer chicken

Background and Aim

With the increased concerns about global protein supply, chicken meat, especially from male layer chicken, constitutes an alternative in terms of quality and carcass traits. Probiotics have been proposed for replacing antibiotic growth promoters (AGPs), which have been prohibited as poultry supplement feeds. The present study aimed to determine the efficacy of dietary supplementary probiotics during the starter period on growth performances, carcass traits, and immune organs of male layer chicken.

Materials and Methods

In this study, one hundred and eighty 1-day-old male chicks from the strain ISA brown were used. They were divided into six groups according to the feed: 100% basal feed (T0), basal feed+2.5 g AGP/kg feed (T1), basal feed+probiotics 1 mL/kg feed (T2), basal feed+probiotics 3 mL/kg feed (T3), basal feed+probiotics 4 mL/kg feed (T4), and basal feed+probiotics 5 mL/kg feed (T5). Probiotics (Lactobacillus acidophilus, Lactobacillus plantarum, and Bifidobacterium spp.) were given at a concentration of 1.2×109 colony-forming unit/mL. Virginiamycin was used as AGP. ISA brown layer chicken was treated for 21 days. Growth performances (body weight, feed consumption, and feed conversion ratio [FCR]), carcass traits (weight at slaughter, weight of the carcass, breast muscles, liver, lungs, kidneys, and heart), immune organs (spleen, thymus, and bursa of Fabricius), and non-edible organs (head, legs, and wings) were analyzed.

Results

Probiotic supplementation at 4 and 5 mL/kg feed (T4 and T5) during the starter phase improved the body weight, FCR, and feed consumption. The weight at slaughter, weight of the carcass, breast muscles, and liver from the T4 and T5 groups were significantly greater than those in the other treatment groups. In addition, the weight of the heart, lungs, and kidneys was increased in the T1, T2, T3, T4, and T5 groups compared with that measured in the T0 group. Furthermore, there were significant differences regarding the immune organs between the T0 and the other treatment groups. The weight of the head, legs, and wings was also greater in the probiotic and AGP supplementation groups (T1, T2, T3, T4, and T5) than that in the basal feed group (T0).

Conclusion

Probiotic (L. acidophilus, L. plantarum, and Bifidobacterium spp.) supplementation at 4 and 5 mL/kg feed during the starter period can be used to improve the growth, carcass traits, and weight of immune organs in male layer chicken.

Impact of feeding modified soy protein concentrate in the starter phase on growth performance and gastrointestinal responses in broiler chickens through to day 42 of age

Growth performance and physiological responses of feeding modified soy protein concentrate (MSPC, 72% CP) in the starter phase were investigated. A total of 1,216 d old male Ross x Ross 708 broiler chicks were placed in 32 floor pens based on BW, fed one of 4 (n = 8) corn-soybean meal-based diets formulated with 0, 7.7, 10.0 or 12.5% MSPC for 10 d and transitioned to common diets to d 42. Feed intake, BW, and mortality were measured. Samples of birds were bled on d 10 for plasma uric acid (PUA) and subsequently necropsied for organs weight and samples of pancreatic tissues for enzyme activity, jejunal tissues for enzyme activity and histomorphology and ceca digesta for microbial activity. Litter moisture was determined on d 36 and 42 and sample of birds were necropsied on d 42 for breast yield and ceca digesta sample for microbial activity. Feeding MSPC linearly (P < 0.001) increased starter growth performance. Overall (d 0-42), MSPC linearly (P = 0.05)improved FCR; The FCR was 1.566, 1.535, 1.488 and 1.527 for 0.0, 7.7, 10.0, and 12.5% MSPC, respectively. Feeding MSPC linearly (P ≤ 0.04) increased breast yield and decreased small intestine length, gizzard digesta pH, and PUA. Breast yield was 230, 238, 246, and 252 g/kg BW for 0.0, 7.7, 10.0, and 12.5% MSPC, respectively. Pancreatic and jejunal chymotrypsin and trypsin activities and histomorphology were not (P > 0.10) influenced by the diets. On d 10, MSPC linearly (P < 0.05) reduced ceca digesta abundance of Ruminococcaceae, E. Coli, and Clostridium but increased abundance of Bifidobacterium and the ratio of Lactobacilli and E. Coli. Birds fed MSPC showed linear (P = 0.01) increase in abundance of Bifidobacterium on d 42. Feeding MSPC linearly increased ceca digesta acetic (P = 0.01) and reduced propionic (P = 0.048), and iso butyric (P = 0.003) in 10 d old broiler chicken. In conclusion, up to 12.5% MSPC inclusion in the starter phase increased growth performance through to d 42 linked to enhanced gut health through reduction of enteric pathogens.